Buy Apretude (Cabotegravir) Injectable HIV PrEP in Philippines: A Comprehensive Guide.

REMARKS: Apretude (Cabotegravir) is currently not available in the Philippines yet. It is currently available in all our Malaysia & Thailand branches. 

If you are interested, please contact our Philippines branch so that we can assist you with an appointment in Malaysia and Thailand

Introduction to Injectable PrEP and Its Importance

Pre-exposure prophylaxis (PrEP) has transformed the fight against HIV by providing a preventive measure for those at high risk of acquiring the virus. While oral PrEP has been a game-changer, injectable PrEP, like Apretude, offers an innovative alternative, addressing adherence challenges and enhancing efficacy. Apretude (cabotegravir) is the first long-acting injectable PrEP approved for HIV prevention, providing consistent protection and convenience for users. In Philippines, access to Apretude represents a critical step in reducing new HIV infections and improving public health.

What Medication is Used As Injectable PrEP?

The active ingredient in Apretude is cabotegravir, an integrase inhibitor that prevents the replication of HIV within the body. Unlike daily oral PrEP options (such as tenofovir disoproxil fumarate/emtricitabine), cabotegravir is administered via an intramuscular injection every two months, offering reliable protection for people at risk of HIV.

Updated Guidelines for Injectable PrEP

Recent guidelines by the World Health Organisation (WHO) and other health authorities recommend injectable PrEP as a viable alternative for individuals who face adherence challenges with daily pills. Key recommendations include:

• Initiating Apretude with two injections administered one month apart.
• Subsequent injections are given every two months.
• Baseline HIV testing to ensure the individual is HIV-negative before starting treatment.

These updated protocols emphasise the importance of comprehensive medical supervision to ensure safety and efficacy.

Advantages of Injectable PrEP Compared to Oral PrEP

1. Improved Adherence: Apretude eliminates the need for daily pills, reducing the risk of missed doses.
2. Consistent Protection: The sustained-release formulation ensures constant protection against HIV.
3. Convenience: Injections every two months make it easier for people with busy lifestyles.
4. Reduced Stigma: Injectable PrEP is discreet, avoiding the visibility of daily pill regimens.

How is Injectable PrEP Administered? What is the protocol?

Apretude is administered via intramuscular injection in a healthcare setting. The standard protocol involves:

1. Initiation Phase:
   • Two 600 mg injections one month apart.
2. Maintenance Phase:
   • One injection every two months.

Healthcare providers in our Philippines HIV Clinic will assess individual health status, perform regular HIV tests, and provide counselling on safe sex practices alongside PrEP use.

REMARKS: Apretude (Cabotegravir) is currently not available in the Philippines yet. It is currently available in all our Malaysia & Thailand branches. 

If you are interested, please contact our Philippines branch so that we can assist you with an appointment in Malaysia and Thailand

Adverse Events and Side Effects of Injectable PrEP

While generally well-tolerated, Apretude may cause side effects, including

• Injection site reactions (pain, swelling, redness).
• Headache or fatigue.
• Fever or nausea.

In rare cases, allergic reactions or liver function changes may occur. It's essential to let your healthcare provider know of any unusual symptoms as soon as possible.

Contraindications & Safety Information of PrEP Injection

Apretude is contraindicated for individuals:

• Diagnosed with HIV.
• With known hypersensitivity to cabotegravir.
• Experiencing active liver disease or significant liver dysfunction.

Pregnant or breastfeeding individuals should consult their healthcare provider to evaluate risks and benefits.

FAQ About Injectable PrEP

1. Is Apretude available in Philippines?
Apretude is not available in Philippines. Please contact our Malaysia and Thailand branches or more information on accessing it.

2. How effective is Apretude?
Clinical trials demonstrate Apretude's effectiveness in reducing HIV risk, surpassing oral PrEP in certain populations.

3. Can I switch from oral PrEP to Apretude?
Yes, transitioning from oral PrEP to Apretude is possible. Your healthcare provider will guide you through the switch to ensure seamless protection.

4. Is injectable PrEP suitable for everyone?
While injectable PrEP is an excellent option for many, it’s not suitable for individuals with certain health conditions or those who cannot commit to regular clinic visits.

Conclusion

Injectable PrEP, such as Apretude, marks a significant advancement in HIV prevention. Its superior adherence, convenience, and efficacy can potentially transform HIV prevention efforts in Philippines. If you’re considering Apretude, consult your healthcare provider to determine if it’s the right choice.

REMARKS: Apretude (Cabotegravir) is currently not available in the Philippines yet. It is currently available in all our Malaysia & Thailand branches. 

If you are interested, please contact our Philippines branch so that we can assist you with an appointment in Malaysia and Thailand